Establishment of a human induced pluripotent stem cell (iPSC) line (HIHDNEi002-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Arg297Gln) mutation.


Journal

Stem cell research
ISSN: 1876-7753
Titre abrégé: Stem Cell Res
Pays: England
ID NLM: 101316957

Informations de publication

Date de publication:
05 2019
Historique:
received: 22 03 2019
revised: 12 04 2019
accepted: 18 04 2019
pubmed: 11 5 2019
medline: 12 3 2020
entrez: 11 5 2019
Statut: ppublish

Résumé

Developmental and epileptic encephalopathies (DEE) can be caused by mutations in the KCNA2 gene, coding for the voltage-gated K+ channel K

Identifiants

pubmed: 31075689
pii: S1873-5061(19)30075-3
doi: 10.1016/j.scr.2019.101445
pii:
doi:

Substances chimiques

KCNA2 protein, human 0
Kv1.2 Potassium Channel 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101445

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Niklas Schwarz (N)

Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Germany. Electronic address: niklas.schwarz@uni-tuebingen.de.

Betül Uysal (B)

Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Germany.

Filip Rosa (F)

Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Germany.

Heidi Löffler (H)

Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Germany.

Ulrike A Mau-Holzmann (UA)

Department of Medical Genetics and Applied Genomics, University of Tuebingen, Germany.

Stefan Liebau (S)

Institute of Neuroanatomy & Developmental Biology, University of Tuebingen, Germany.

Holger Lerche (H)

Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH